ARCHIVES

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

This article is from The Cancer Letter archive.

Vol. 20 No. 38 | October 7, 1994

Download PDF Visit The Full Archive

Related Articles

Institutions Required To Review For Bias under PHS Proposal

July 22, 1994

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

Obit: Same Shapiro, Proponent of Mammographic Screening.

January 7, 2000

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

Backing Down On Forward Funding? HHS Now Says It Won’t Make Multiple Year Awards Until September

April 5, 1985

Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me

December 13, 2013